Clinical Trial: Rupatadine Tablets for the Treatment of Refractory Urticaria: Clinical Characteristics, Treatment Response, and Predictive Indicators (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Rupatadine Tablets for the Treatment of Refractory Urticaria: Clinical Characteristics, Treatment Response, and Predictive Indicators'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132950

Registration Time: 2026/09/20

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Army Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339566

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Rupatadine Tablets for the Treatment of Refractory Urticaria: Clinical Characteristics, Treatment Response, and Predictive Indicators (China)